Phase I Trial of Intraperitoneal (IP) Administration of a Measles Virus (MV) Strain Expressing the Human Carcinoembryonic Antigen (CEA) in Ovarian Cancer Patients

被引：0
|
作者：
Galanis, Evanthia [1 ]
Hartmann, Lynn C. [1 ]
Cliby, William A. [1 ]
Zollman, Paula [1 ]
Peethambaram, Prema P. [1 ]
Long, Harry J. [1 ]
Kaur, Judith S. [1 ]
Sloan, Jeff A. [1 ]
Poland, Gregory A. [1 ]
Peng, Kah-Whye [1 ]
Russell, Stephen J. [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.809
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
729
引用
收藏
页码：S281 / S281
页数：1
相关论文
共 50 条
  • [21] A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer
    Eder, JP
    Kantoff, PW
    Roper, K
    Xu, GX
    Bubley, GJ
    Boyden, J
    Gritz, L
    Mazzara, G
    Oh, WK
    Arlen, P
    Tsang, KY
    Panicali, D
    Schlom, J
    Kufe, DW
    CLINICAL CANCER RESEARCH, 2000, 6 (05) : 1632 - 1638
  • [22] A Phase I Trial of Vaccination with Carcinoembryonic Antigen (CEA) and Her2/neu (Her2) Peptides in Advanced Colorectal Cancer
    Lynch, Kevin T.
    Squeo, Gabriella C.
    Kane, William J.
    Meneveau, Max O.
    Olson, Walter C.
    Petroni, Gina
    Slingluff, Craig L., Jr.
    Foley, Eugene F.
    Friel, Charles M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S51 - S52
  • [23] A PHASE-I-II TRIAL OF INTRAPERITONEAL (IP) CISPLATIN (P) + MELPHALAN (M) IN OVARIAN-CANCER (OVCA) AND INTRAABDOMINAL MALIGNANCIES
    PICCART, MJ
    ABRAMS, J
    DODION, P
    CRESPEIGNE, N
    SCULIER, JP
    PECTOR, J
    HOCHSTER, H
    ATASSI, G
    KENIS, Y
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 62 - 62
  • [24] A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen
    Morse, MA
    Deng, YP
    Coleman, D
    Hull, S
    Kitrell-Fisher, E
    Nair, S
    Schlom, J
    Ryback, ME
    Lyerly, HK
    CLINICAL CANCER RESEARCH, 1999, 5 (06) : 1331 - 1338
  • [25] Safety of Repeat Intracerebral Administration of MV-CEA in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas
    Myers, Rae M.
    Harvey, Mary E.
    Greiner, Suzanne M.
    Soeffker, Diane C.
    Krempski, James W.
    Zollman, Paula J.
    Shelton, Steven E.
    Corey, Raffel
    Stephan, Goerss J.
    Timothy, Kaufmann J.
    Mark, Federspiel J.
    Kah-Whye, Peng
    Stephen, Russell J.
    Evanthia, Galanis
    MOLECULAR THERAPY, 2006, 13 : S113 - S113
  • [26] Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma
    Dispenzieri, A.
    Tong, C.
    LaPlant, B.
    Lacy, M. Q.
    Laumann, K.
    Dingli, D.
    Zhou, Y.
    Federspiel, M. J.
    Gertz, M. A.
    Hayman, S.
    Buadi, F.
    O'Connor, M.
    Lowe, V. J.
    Peng, K-W
    Russell, S. J.
    LEUKEMIA, 2017, 31 (12) : 2791 - 2798
  • [27] Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma
    A Dispenzieri
    C Tong
    B LaPlant
    M Q Lacy
    K Laumann
    D Dingli
    Y Zhou
    M J Federspiel
    M A Gertz
    S Hayman
    F Buadi
    M O'Connor
    V J Lowe
    K-W Peng
    S J Russell
    Leukemia, 2017, 31 : 2791 - 2798
  • [28] FIRST-IN-HUMAN PHASE I CLINICAL TRIAL EVALUATING INTRAPERITONEAL ADMINISTRATION OF MOV19-BBZ CAR T CELLS IN PATIENTS WITH ALPHA FOLATE RECEPTOR-EXPRESSING RECURRENT HIGH GRADE SEROUS OVARIAN CANCER
    Shah, Payal
    Shlanksy-Goldberg, Richard
    Martin, Lainie
    Nadolski, Gregory
    Hexner, Elizabeth
    Shamimi-Noori, Susan
    Hwang, Wei-Ting
    Matlawski, Tina
    Cervini, Amanda
    Shea, Joanne
    Nelson, Lauren
    Lacey, Simon
    Plesa, Gabriela
    Lledo, Lester
    Dengel, Karen
    Marshall, Amy
    Leskowitz, Rachel
    Kandalaft, Lana
    Figini, Mariangela
    Canevari, Silvana
    Coukos, George
    Powell, Daniel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A461 - A461
  • [29] Phase Ia trial of a polynucleotide anti-tumor immunization to human carcinoembryonic antigen in patients with metastatic colorectal cancer
    Conry, RM
    LoBuglio, AF
    Curiel, DT
    HUMAN GENE THERAPY, 1996, 7 (06) : 755 - 772
  • [30] Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule
    Hörig, H
    Lee, DS
    Conkright, W
    Divito, J
    Hasson, H
    LaMare, M
    Rivera, A
    Park, D
    Tine, J
    Guito, K
    Tsang, KWY
    Schlom, J
    Kaufman, HL
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (09) : 504 - 514
12345